US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the scientists of its research...
Veritas’ Research Arm Cannevert Therapeutics Signs Letter of Intent with Fundación de Investigación (FDI) of Puerto Rico USA to Begin Human Trials of Its Lead Cannabis Strain for Pain
20 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert...
Veritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing Facility
18 nov. 2017 16h44 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 18, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”), an emerging-stage pharmaceutical and IP...
Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski
14 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has initiated a cancer...
Veritas and Cannevert Hires the Essèntium Group as Their Agent in Puerto Rico USA
13 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the Company through its research...
A Provisional Patent Application for Use of Specific Cannabis Strain in Neuropathic Pain Filed With the US Patent Office
07 nov. 2017 04h00 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert...